Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$329.79 CAD
Change Today -4.12 / -1.23%
Volume 605.5K
As of 4:21 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Howard Bradley Schiller

AgeTotal Calculated CompensationThis person is connected to 143 board members in 4 different organizations across 10 different industries.

See Board Relationships
53$27,112,617
As of Fiscal Year 2014

Background*

Mr. Howard Bradley Schiller serves as Consultant of Valeant Pharmaceuticals International, Inc. and served as its Chief Financial Officer and Executive Vice President from December 2011 to June 2015 and its Principal Accounting Officer. Mr. Schiller serves as a Chief Financial Officer and an Executive Vice President at Valeant Pharmaceuticals North America LLC. He served as Executive Vice President and Chief Financial Officer of Coria Laboratories, Ltd. He has been Treasurer ...

Read Full Background

Corporate Headquarters*

2150 St. Elzéar boulevard West
Laval, Quebec H7L 4A8

Canada

Phone: 514-744-6792
Fax: 514-744-6272

Board Members Memberships*

Trustee
2012-Present
Consultant and Director
2014-Present
Treasurer and Director
2015-Present
Director

Education*

JD
University of Chicago Law School
BS
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Salary$953,846
Total Annual Compensation$953,846

Stock Options*

Restricted Stock Awards$23,730,659
All Other Compensation$28,112
Exercisable Options150,000
Exercisable Options Value$14,535,000
Unexercisable Options50,000
Unexercisable Options Value$4,845,000
Total Value of Options$19,380,000
Total Number of Options200,000

Total Compensation*

Total Annual Cash Compensation$3,381,958
Total Short Term Compensation$953,846
Other Long Term Compensation$23,758,771
Total Calculated Compensation$27,112,617
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRX:CN C$329.79 CAD -4.12

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$916.0K
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$2.0M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.4M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
¥182.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VALEANT PHARMACEUTICALS INTE, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.